Can cannabis gummies cause urinary retention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cannabis Gummies and Urinary Retention

Cannabis gummies are not typically associated with urinary retention; in fact, cannabinoids appear more likely to cause increased urination (diuresis) rather than retention. The available evidence does not support urinary retention as a recognized adverse effect of cannabis products, including edibles like gummies.

Evidence from Guidelines

The most recent and comprehensive guidelines on cannabis use 1, 2 extensively detail adverse effects including:

  • Cannabinoid hyperemesis syndrome
  • Cardiovascular effects (arrhythmias, orthostatic hypotension)
  • Respiratory complications
  • Psychiatric risks (depression, psychosis, cannabis use disorder)
  • Driving impairment
  • Central nervous system depression in acute toxicity

Notably absent from these authoritative 2024 guidelines is any mention of urinary retention as a side effect of cannabis use. This is significant given the comprehensive nature of these safety reviews from ASCO and the American College of Physicians.

Research Evidence on Urinary Effects

The research literature actually suggests opposite effects on the urinary system:

  • Diuretic effects predominate: A 2024 mechanistic study 3 demonstrated that cannabinoid receptor activation causes water diuresis by inducing central diabetes insipidus in mice, leading to large volumes of dilute urine—the opposite of retention.

  • Association with overactive bladder: A 2023 cross-sectional study 4 found regular marijuana use was associated with overactive bladder symptoms (OR 1.39), suggesting increased urinary frequency rather than retention.

  • Pediatric data shows increased LUTS: A 2025 study 5 found cannabis use disorder in pediatric patients was associated with increased diagnoses of dysuria, UTIs, and pelvic pain—but not specifically retention.

The Single Case Report Caveat

One 2024 case report 6 described urinary retention in a patient using both methamphetamine and cannabis concomitantly. However, this patient had multiple confounding factors including:

  • Concurrent methamphetamine use (a known cause of urinary retention)
  • Acute delirium
  • No prior psychiatric history

This single case with multiple confounders does not establish causation for cannabis alone, especially when methamphetamine is well-recognized to cause urinary retention through its sympathomimetic effects.

Mechanism Considerations

Research on cannabinoid effects on bladder function 7 shows that non-psychotropic cannabinoids like cannabigerol (CBG) actually reduce bladder contractility in vitro, which theoretically could impair voiding. However, clinical translation has not demonstrated retention as a meaningful adverse effect in human studies.

Clinical Bottom Line

If a patient using cannabis gummies presents with urinary retention, look for alternative explanations first:

  • Prostatic obstruction (in males)
  • Anticholinergic medications
  • Opioid use
  • Neurologic conditions
  • Concurrent substance use (particularly stimulants like methamphetamine)
  • Anatomic abnormalities

The evidence does not support counseling patients that cannabis gummies cause urinary retention. The more relevant urinary counseling points based on current evidence 3, 4 would be potential for increased urinary frequency and overactive bladder symptoms.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.